We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

214 hedge funds and large institutions have $1.82B invested in Beam Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $7.11M

18% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 62

8.14% more ownership

Funds ownership: 86.14% → 94.28% (+8.1%)

3% less funds holding

Funds holding: 221 → 214 (-7)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

22% less capital invested

Capital invested by funds: $2.32B → $1.82B (-$504M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
214
Holders Change
-7
Holders Change %
-3.17%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
36
Increased
73
Reduced
62
Closed
41
Calls
$16.6M
Puts
$7.11M
Net Calls
+$9.45M
Net Calls Change
+$24.8M

Top Buyers

1
AVM
Arch Venture Management
Illinois
+$134M
2
FCM
Farallon Capital Management
California
+$83.5M
3
First Trust Advisors
First Trust Advisors
Illinois
+$36.4M
4
BlackRock
BlackRock
New York
+$22.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$19.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$81.5M
2
DGM
Darwin Global Management
Jersey
-$70M
3
AIM
ARK Investment Management
Florida
-$13.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$12M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
51
Walleye Capital
New York
$2.46M +$177K +7,187 +7%
Qube Research & Technologies (QRT)
52
Qube Research & Technologies (QRT)
United Kingdom
$2.4M +$106K +4,304 +4%
American Century Companies
53
American Century Companies
Missouri
$2.24M +$585K +23,837 +33%
Citigroup
54
Citigroup
New York
$2.12M -$4.15M -168,851 -65%
AllianceBernstein
55
AllianceBernstein
Tennessee
$2.06M – – –
VAS
56
Vestmark Advisory Solutions
Massachusetts
$1.96M -$766K -31,207 -27%
Barclays
57
Barclays
United Kingdom
$1.92M -$119K -4,849 -6%
Millennium Management
58
Millennium Management
New York
$1.89M -$647K -26,343 -25%
LIP
59
Liontrust Investment Partners
United Kingdom
$1.87M +$1.96M +80,000 New
Capital Fund Management (CFM)
60
Capital Fund Management (CFM)
France
$1.82M +$1.51M +61,509 +380%
ACM
61
ADAR1 Capital Management
Texas
$1.71M +$1.79M +72,800 New
DekaBank Deutsche Girozentrale
62
DekaBank Deutsche Girozentrale
Germany
$1.7M – – –
Legal & General Group
63
Legal & General Group
United Kingdom
$1.66M -$71.7K -2,919 -4%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$1.6M -$37.3K -1,519 -2%
Invesco
65
Invesco
Georgia
$1.52M -$16.6K -677 -1%
Wells Fargo
66
Wells Fargo
California
$1.45M +$365K +14,880 +32%
CGL
67
Clarius Group LLC
Washington
$1.42M – – –
Massachusetts Financial Services
68
Massachusetts Financial Services
Massachusetts
$1.38M +$1.45M +59,095 New
SRL
69
Scientech Research LLC
New Jersey
$1.22M +$797K +32,469 +167%
KF
70
Krilogy Financial
Missouri
$1.2M +$436K +17,734 +53%
DADC
71
D.A. Davidson & Co
Montana
$1.16M +$139K +5,672 +13%
Tudor Investment Corp
72
Tudor Investment Corp
Connecticut
$1.15M +$28.9K +1,177 +2%
GC
73
Guggenheim Capital
Illinois
$1.1M -$32.3K -1,316 -3%
Lazard Asset Management
74
Lazard Asset Management
New York
$1.1M -$201K -8,177 -15%
State of Wisconsin Investment Board
75
State of Wisconsin Investment Board
Wisconsin
$1.1M -$61.9K -2,521 -5%
1 2
3
4 5

BEAM Hedge Fund Activity: Q2 2024 in Review

214 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2024, worth a combined $1.82B — down 22% from $2.32B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of BEAM and 36 opened new positions — a net loss of 5 holders — while 62 trimmed existing stakes and 73 added.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $134M. The largest seller was Morgan Stanley, cutting an estimated $81.5M.

  • 214 institutional investors held Beam Therapeutics (BEAM) as of Q2 2024, down from 221 in Q1 2024.
  • Funds reported $1.82B of Beam Therapeutics stock for Q2 2024, down 22% quarter-over-quarter.
  • 36 funds opened new Beam Therapeutics positions in Q2 2024 and 41 closed out, a net change of -5 holders.
  • The largest Beam Therapeutics buyer in Q2 2024 was Arch Venture Management, an estimated $134M added.
  • The largest Beam Therapeutics seller in Q2 2024 was Morgan Stanley, an estimated $81.5M sold.

Based on aggregated 13F filings for Q2 2024.